Dividend Power Score
A single, comprehensive score designed to measure the true strength of a company’s dividend.
This score combines three essential pillars of dividend quality:
Consistency – Measures how reliable the dividend has been over time, focusing on payment history, stability, and the absence of cuts or suspensions.
Payability – Assesses the company’s financial ability to sustain its dividend, taking into account cash flow, earnings coverage, balance sheet strength, and overall financial health.
Growth – Evaluates the long-term growth of both the dividend and the company’s share price, highlighting businesses that consistently increase payouts while creating shareholder value.
Higher scores identify companies that have historically delivered dependable income alongside sustained dividend growth and long-term capital appreciation.
Company Overview
Ansell Limited is a global manufacturer of personal protective equipment (PPE) and safety solutions, primarily serving the healthcare and industrial sectors. The company develops and sells protective gloves, medical exam gloves, surgical gloves, chemical-resistant apparel, body protection products, and workplace safety solutions used in environments where infection control, worker safety, and contamination prevention are critical. Ansell operates across the broader healthcare, industrial safety, life sciences, and occupational protection industries, with revenue primarily driven by sales to hospitals, healthcare providers, industrial manufacturers, laboratories, distributors, and government agencies.
Founded in Australia in 1929, Ansell originally developed from a rubber products business associated with protective glove manufacturing. Over time, the company expanded internationally through acquisitions, product innovation, and manufacturing scale. Ansell is recognized for its established global distribution network, broad product portfolio, and strong positioning in both disposable and reusable protective equipment categories. Its strategy has increasingly focused on premium-value products, automation, healthcare safety solutions, and industrial protection technologies.
Business Operations
Ansell organizes its operations primarily around the Healthcare Global Business Unit and the Industrial Global Business Unit. The healthcare segment includes surgical gloves, examination gloves, and cleanroom products used by hospitals, healthcare systems, and pharmaceutical environments. The industrial segment includes hand and body protection products for manufacturing, automotive, chemical processing, mining, oil and gas, and life sciences applications. Revenue is generated through direct sales, distributor partnerships, and long-term procurement relationships with healthcare systems and industrial customers.
The company maintains manufacturing facilities and supply chain operations across multiple countries in Asia-Pacific, Europe, and the Americas, with significant production capacity in countries such as Malaysia, Sri Lanka, Thailand, Vietnam, and India. Ansell owns a portfolio of brands and technologies associated with hand protection, chemical resistance, and workplace safety. Key subsidiaries and operating brands include Ansell Healthcare, Ansell Industrial, and acquired businesses integrated into its protective solutions platform. The company also maintains partnerships with distributors and healthcare procurement organizations to support global market access.
Strategic Position & Investments
Ansell’s strategic direction has centered on expanding higher-margin product categories, strengthening healthcare protection technologies, and growing industrial safety offerings through acquisitions and operational investments. The company has pursued targeted acquisitions to broaden its portfolio in specialized protective equipment and to deepen exposure to regulated safety markets. Notable acquisitions in recent years have included Protective Industrial Products (PIP)-related assets discussions in sector competition contexts, as well as completed acquisitions such as Ringers Gloves and Careplus Group, which enhanced Ansell’s industrial safety and medical device capabilities respectively.
The company has also invested in automation, supply chain resilience, and product innovation focused on chemical protection, infection prevention, and ergonomic safety solutions. Emerging areas of focus include cleanroom technologies, life sciences protection, sustainability initiatives in manufacturing, and advanced material technologies for high-risk industrial applications. Ansell’s strategy emphasizes operational efficiency, premium product differentiation, and expansion in regulated end markets where safety compliance requirements support long-term demand.
Geographic Footprint
Ansell Limited is headquartered in Melbourne, Australia, and maintains a broad international operating footprint spanning North America, Europe, Asia-Pacific, Latin America, and parts of the Middle East and Africa. The company generates substantial revenue from the United States and Europe, while much of its manufacturing infrastructure is concentrated in Asian markets to support global distribution efficiency and scale production.
The company operates through regional sales offices, manufacturing plants, research facilities, and distribution networks across multiple continents. Ansell’s products are sold in more than 100 countries through direct commercial operations and third-party distributors. Its global manufacturing and sourcing model gives the company exposure to both developed and emerging markets, while supporting multinational healthcare systems and industrial customers with standardized safety products and supply continuity.
Leadership & Governance
Ansell Limited operates under a corporate governance framework overseen by its board of directors and executive leadership team. The company’s leadership strategy has emphasized operational discipline, portfolio optimization, product innovation, and global market expansion in healthcare and industrial protection. Public company disclosures indicate a continued focus on sustainable growth, supply chain resilience, and maintaining leadership positions in specialized PPE categories.
Key executives include:
- Neil Salmon – Managing Director and Chief Executive Officer
- Zubair Javeed – Chief Financial Officer
- Marcel Blattner – Senior Vice President and General Manager, Healthcare Global Business Unit
- David Landgaard – Senior Vice President and General Manager, Industrial Global Business Unit
- Andrew Price – Chief Supply Chain Officer
- Michele Lohuis – Chief Human Resources Officer
The company’s governance and operational disclosures are primarily communicated through SEC filings, annual reports, investor presentations, and Australian market disclosures. Publicly available information consistently identifies Ansell as a globally diversified PPE manufacturer with integrated healthcare and industrial safety operations.